Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast CancerSofia Agelaki(University of Crete), Vassilis Georgoulias(University Hospital of Heraklion)PLoS ONEJune 17, 201510.1371/journal.pone.0123683Cited by 58SaveCiteExport RISWatch citationsRelated PapersEpithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients|Breast Cancer Research|2011|373Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer|Cancers|2020|88Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes|Molecular Oncology|2017|17